Journal
INTENSIVE CARE MEDICINE
Volume 44, Issue 5, Pages 627-635Publisher
SPRINGER
DOI: 10.1007/s00134-018-5247-0
Keywords
Cross infection; Immunoparesis; Immunophenotyping; Monocytes; Neutrophils; T-lymphocytes; regulatory
Categories
Funding
- Innovate UK [101193]
- BD Biosciences
- National Institute for Academic Anaesthesia
- Clinical Research Career Development Fellowship from the Wellcome Trust [WT 2055214/Z/16/Z]
- National Institute for Health Research Clinician Scientist Award [CS-2016-16011]
- Innovate UK [101193] Funding Source: UKRI
Ask authors/readers for more resources
Purpose: Cellular immune dysfunctions, which are common in intensive care patients, predict a number of significant complications. In order to effectively target treatments, clinically applicable measures need to be developed to detect dysfunction. The objective was to confirm the ability of cellular markers associated with immune dysfunction to stratify risk of secondary infection in critically ill patients. Methods: Multi-centre, prospective observational cohort study of critically ill patients in four UK intensive care units. Serial blood samples were taken, and three cell surface markers associated with immune cell dysfunction [neutrophil CD88, monocyte human leucocyte antigen-DR (HLA-DR) and percentage of regulatory T cells (T-regs)] were assayed on-site using standardized flow cytometric measures. Patients were followed up for the development of secondary infections. Results: A total of 148 patients were recruited, with data available from 138. Reduced neutrophil CD88, reduced monocyte HLA-DR and elevated proportions of T-regs were all associated with subsequent development of infection with odds ratios (95% CI) of 2.18 (1.00-4.74), 3.44 (1.58-7.47) and 2.41 (1.14-5.11), respectively. Burden of immune dysfunction predicted a progressive increase in risk of infection, from 14% for patients with no dysfunction to 59% for patients with dysfunction of all three markers. The tests failed to risk stratify patients shortly after ICU admission but were effective between days 3 and 9. Conclusions: This study confirms our previous findings that three cell surface markers can predict risk of subsequent secondary infection, demonstrates the feasibility of standardized multisite flow cytometry and presents a tool which can be used to target future immunomodulatory therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available